Takeda Pharmaceutical Co.’s Thousand Oaks facility hosted a groundbreaking ceremony on July 22, celebrating the $126 million expansion of the facility’s manufacturing capabilities.

The Tokyo-headquartered company’s facility is a vertically integrated bioprocessing plant that specializes in manufacturing products to increase the quality of life for those with rare diseases.

About two years in the making, the $126 million expansion aims to strengthen manufacturing operations. It includes a renovation of about 15,000 square feet of existing space and the addition of another 15,000 square feet of manufacturing space.

...

Join our Membership to get the full story.


Are you a current Member? Sign In